Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-23

Clinical Trial Update: Spironolactone Versus Prednisolone in DMD [Phase 1]

View source ↗

Summary

Phase 1 trial comparing spironolactone versus prednisolone in Duchenne muscular dystrophy was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)
  • Spironolactone (spironolactone)

Snippet

Sponsor: Kevin Flanigan | Conditions: Muscular Dystrophy, Duchenne | Phase 1 | Status: TERMINATED | Results posted: 2023-10-23